(Circulation. 2000;102:1814.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Departments of Medicine, The Prince Charles Hospital; Physiology and Pharmacology, University of Queensland, Queensland (P.M.); the Department of Pharmacology, University of Melbourne, Victoria, Australia (P.M., K.B.); Max-Delbrück Center of Molecular Medicine, Cardiology, Berlin, Germany (S.B., D.V., P.K., E.G.K.); Victorian Paediatric Cardiac Surgical Unit, Royal Childrens Hospital, Parkville, Australia (A.C.); the Department of Cardiac Surgery, The Prince Charles Hospital, Queensland (H.J., P.P.); Babraham Institute, Cambridge, and the Department of Physiology, University of Cambridge, UK (A.K.).
Correspondence to Dr Peter Molenaar, Department of Medicine, University of Queensland, The Prince Charles Hospital, Chermside, Queensland, 4032, Australia. E-mail molenaar{at}medicine.uq.edu.au
BackgroundIn adult human heart, both ß1- and ß2-adrenergic receptors mediate hastening of relaxation; however, it is unknown whether this also occurs in infant heart. We compared the effects of stimulation of ß1- and ß2-adrenergic receptors on relaxation and phosphorylation of phospholamban and troponin I in ventricle obtained from infants with tetralogy of Fallot.
Methods and ResultsMyocardium dissected from the right ventricular outflow tract of 27 infants (age range 21/2 to 35 months) with tetralogy of Fallot was set up to contract 60 times per minute. Selective stimulation of ß1-adrenergic receptors with (-)-norepinephrine (NE) and ß2-adrenergic receptors with (-)-epinephrine (EPI) evoked phosphorylation of phospholamban (at serine-16 and threonine-17) and troponin I and caused concentration-dependent increases in contractile force (-log EC50 [mol/L] NE 5.5±0.1, n=12; EPI 5.6±0.1, n=13 patients), hastening of the time to reach peak force (-log EC50 [mol/L] NE 5.8±0.2; EPI 5.8±0.2) and 50% relaxation (-log EC50 [mol/L] NE 5.7±0.2; EPI 5.8±0.1). Ventricular membranes from Fallot infants, labeled with (-)-[125I]-cyanopindolol, revealed a greater percentage of ß1- (71%) than ß2-adrenergic receptors (29%). Binding of (-)-epinephrine to ß2-receptors underwent greater GTP shifts than binding of (-)-norepinephrine to ß1-receptors.
ConclusionsDespite their low density, ß2-adrenergic receptors are nearly as effective as ß1-adrenergic receptors of infant Fallot ventricle in enhancing contraction, relaxation, and phosphorylation of phospholamban and troponin I, consistent with selective coupling to Gs-protein.
Key Words: tetralogy of Fallot catecholamines myocardial contraction receptors, adrenergic, beta
This article has been cited by other articles:
![]() |
J. G. Ryall, J. D. Schertzer, K. T. Murphy, A. M. Allen, and G. S. Lynch Chronic {beta}2-adrenoceptor stimulation impairs cardiac relaxation via reduced SR Ca2+-ATPase protein and activity Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2587 - H2595. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ding, R. F. Wiegerinck, M. Shen, A. Cojoc, C. M. Zeidenweber, and M. B. Wagner Dopamine increases L-type calcium current more in newborn than adult rabbit cardiomyocytes via D1 and {beta}2 receptors Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2327 - H2335. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Molenaar, T. Christ, U. Ravens, and A. Kaumann Carvedilol blocks {beta}2- more than {beta}1-adrenoceptors in human heart Cardiovasc Res, January 1, 2006; 69(1): 128 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Heubach, U. Ravens, and A. J. Kaumann Epinephrine Activates Both Gs and Gi Pathways, but Norepinephrine Activates Only the Gs Pathway through Human {beta}2-Adrenoceptors Overexpressed in Mouse Heart Mol. Pharmacol., May 1, 2004; 65(5): 1313 - 1322. [Abstract] [Full Text] |
||||
![]() |
M. J. Lohse, S. Engelhardt, and T. Eschenhagen What Is the Role of {beta}-Adrenergic Signaling in Heart Failure? Circ. Res., November 14, 2003; 93(10): 896 - 906. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bartel, E.-G. Krause, G. Wallukat, and P. Karczewski New insights into {beta}2-adrenoceptor signaling in the adult rat heart Cardiovasc Res, March 1, 2003; 57(3): 694 - 703. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Kilts, T. Akazawa, M. D. Richardson, and M. M. Kwatra Age Increases Cardiac Galpha i2 Expression, Resulting in Enhanced Coupling to G Protein-coupled Receptors J. Biol. Chem., August 16, 2002; 277(34): 31257 - 31262. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Lohse and S. Engelhardt Protein Kinase A Transgenes: The Many Faces of cAMP Circ. Res., November 23, 2001; 89(11): 938 - 940. [Full Text] [PDF] |
||||
![]() |
E. Devic, Y. Xiang, D. Gould, and B. Kobilka beta -Adrenergic Receptor Subtype-Specific Signaling in Cardiac Myocytes from beta 1 and beta 2 Adrenoceptor Knockout Mice Mol. Pharmacol., September 1, 2001; 60(3): 577 - 583. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |